GALT Q1 2026 Earnings WiderThanExpected Loss as ClinicalStage Biotech Continues RD Spend Five9 Q1 2026 Earnings EPS Surges Past Estimates Stock Retreats Amid Market Uncertainty LUCD Q1 2026 Earnings EPS Misses Estimates Amid PreRevenue Status CIMN Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Market Reaction PRGS Q1 2026 Earnings Modest EPS Beat Amidst Solid Operational Performance RCT Q4 2025 Earnings Significant EPS Miss Amidst Limited Revenue Disclosure OIS Q1 2026 Earnings EPS Slightly Exceeds Estimates Amid Mixed Market Conditions NVO Q1 2026 Earnings EPS Surges Past Estimates as Obesity Drug Sales Drive Margin Gains VALN Q1 2026 Earnings EPS Misses Expectations Amid Ongoing Operational Challenges FGBIP Q1 2026 Earnings EPS Surges 96 Above Estimates Stock Edges Lower SLMBP Q1 2026 Earnings EPS Surges Past Estimates Preferred Stock Holds Steady AB Q1 2026 Earnings EPS Misses Estimates Amid Market Headwinds TYGO Q1 2026 Earnings Modest Beat on Bottom Line as Solar Enabler Navigates Industry Headwinds